Spero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spero Therapeutics, Inc. has filed 506 SEC EDGAR filings since 21 Mar 2017

SEC filing history

Showing 51-75 of 506 matching filings.

Per page
25
Current page
3
DEF 14A File 001-38266

DEF 14A

Filing date
28 Apr 2025
Reporting date
12 Jun 2025
Next action
Verify source filing
SCHEDULE 13D/A File 005-90168

SCHEDULE 13D/A filing

Filing date
28 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90168

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Aug 2024
Reporting date
27 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Aug 2024
Reporting date
27 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Aug 2024
Reporting date
27 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Aug 2024
Reporting date
02 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-281245

S-8

Filing date
05 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .